Mwanzo2196 • HKG
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Bei iliyotangulia
$Â 21.08
Bei za siku
$Â 21.00 - $Â 21.36
Bei za mwaka
$Â 12.44 - $Â 29.00
Thamani ya kampuni katika soko
74.53B HKD
Wastani wa hisa zilizouzwa
4.20M
Uwiano wa bei na mapato
15.86
Mgao wa faida
1.65%
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 9.88B | -5.46% |
Matumizi ya uendeshaji wa biashara | 4.04B | -3.24% |
Mapato halisi | 821.33M | 4.52% |
Kiwango cha faida halisi | 8.31 | 10.51% |
Mapato kwa kila hisa | — | — |
EBITDA | 1.39B | -9.66% |
Asilimia ya kodi ya mapato | 14.57% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 13.51B | -13.59% |
Jumla ya mali | 118.12B | 2.48% |
Jumla ya dhima | 57.31B | 2.21% |
Jumla ya hisa | 60.81B | — |
hisa zilizosalia | 2.64B | — |
Uwiano wa bei na thamani | 1.16 | — |
Faida inayotokana na mali | 1.60% | — |
Faida inayotokana mtaji | 1.95% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 821.33M | 4.52% |
Pesa kutokana na shughuli | 1.25B | 15.57% |
Pesa kutokana na uwekezaji | -652.10M | -410.17% |
Pesa kutokana na ufadhili | -1.78B | -12.01% |
Mabadiliko halisi ya pesa taslimu | -1.28B | -228.19% |
Mtiririko huru wa pesa | -3.64B | -20.82% |
Kuhusu
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1994
Tovuti
Wafanyakazi
40,234
